gene

AMYLOID

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about AMYLOID: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

6550Connections
30Hypotheses
0Analyses
50Outgoing
50Incoming
2Experiments
0Debates

Summary

AMYLOID is a gene implicated in neurodegeneration research. Key relationships include: associated with, activates, inhibits. Associated with ALS, ALZHEIMER, ALZHEIMER'S. Connected to 2116 entities in the SciDEX knowledge graph.

View on Wiki →

AI portrait of AMYLOID

AI-generated illustration · click image to enlarge

Regenerate portrait ↻
🧬 Gene Info
Gene SymbolAMYLOID
Associated DiseasesAging, Als, Alzheimer, Alzheimer Disease, ALZHEIMER'S DISEASE
Known Drugs/CompoundsDONANEMAB, LECANEMAB, MELATONIN, NICOTINAMIDE, RAPAMYCIN, SEMAGLUTIDE
InteractionsA2M, ABCA1, ABCA7, ABI3, ACE, ACETYLCHOLINE
KG Connections4765 knowledge graph edges
DatabasesGeneCardsUniProtNCBI GeneHPASTRING

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

amyloid-beta-metalloproteinases

mechanism · 4656 words

Pathway Diagram

graph TD
    subgraph Pathology["Pathology"]
        AMYLOID["AMYLOID"] -->|"associated with"| MICROGLIA["MICROGLIA"]
        AMYLOID["AMYLOID"] -->|"associated with"| TAU["TAU"]
        AMYLOID["AMYLOID"] -->|"associated with"| BACE1["BACE1"]
        AMYLOID["AMYLOID"] -->|"associated with"| AUTOPHAGY["AUTOPHAGY"]
        AMYLOID["AMYLOID"] -->|"associated with"| APOPTOSIS["APOPTOSIS"]
        AMYLOID["AMYLOID"] -->|"associated with"| GFAP["GFAP"]
        AMYLOID["AMYLOID"] -->|"associated with"| NEURON["NEURON"]
        AMYLOID["AMYLOID"] -->|"associated with"| SOD1["SOD1"]
        AMYLOID["AMYLOID"] -->|"associated with"| NLRP3["NLRP3"]
        AKT["AKT"] -->|"associated with"| AMYLOID["AMYLOID"]
    end
    subgraph Signaling["Signaling"]
        OXIDATIVE_STRESS["OXIDATIVE STRESS"] -->|"activates"| AMYLOID["AMYLOID"]
        ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"] -->|"activates"| AMYLOID["AMYLOID"]
        ALZHEIMER["ALZHEIMER"] -->|"activates"| AMYLOID["AMYLOID"]
        ALZHEIMER_S_DISEASE_1["ALZHEIMER'S DISEASE"] -.->|"inhibits"| AMYLOID["AMYLOID"]
        ALZHEIMER_2["ALZHEIMER"] -.->|"inhibits"| AMYLOID["AMYLOID"]
    end
    style AMYLOID fill:#4a1a6b,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0,font-weight:bold
    style MICROGLIA fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style TAU fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style BACE1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style AUTOPHAGY fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style APOPTOSIS fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style GFAP fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style NEURON fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style SOD1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style NLRP3 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style AKT fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style OXIDATIVE_STRESS fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style ALZHEIMER_S_DISEASE fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style ALZHEIMER fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style ALZHEIMER_S_DISEASE_1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style ALZHEIMER_2 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0

Outgoing (2886)

TargetRelationTypeStr
NEUROINFLAMMATIONinhibitsgene1.00
Neuroinflammationinhibitsdisease1.00
Dementiacausesdisease1.00
Inflammationassociated_withdisease1.00
Autophagyactivatespathway1.00

Incoming (3664)

SourceRelationTypeStr
NEURODEGENERATIONassociated_withgene1.00
ALZHEIMER'S DISEASEassociated_withgene1.00
OXIDATIVE STRESStherapeutic_targetgene1.00
INFLAMMATIONassociated_withgene1.00
AMPKassociated_withgene1.00

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Closed-loop optogenetic targeting PV interneurons to restore 0.952 Alzheimer's disease Circuit-level neural dynamics in neurode
H1: TREM2 Agonism to Redirect APOE4-Enhanced Microglia from 0.921 neurodegeneration TREM2 in Alzheimer's Disease: Mechanisms
TREM2-Deficient Microglia as Drivers of Amyloid Plaque Toxic 0.827 neurodegeneration Legacy Pre-Pipeline Hypothesis Import
Closed-loop transcranial focused ultrasound to restore hippo 0.827 Alzheimer's disease Circuit-level neural dynamics in neurode
CLU/APOE Duality in Amyloid Clearance Determines Cell-Type-S 0.811 neurodegeneration What are the cell-type-specific transcri
Vicious Cycle Hypothesis: Cholinergic Dysfunction Exacerbate 0.785 - Do β-amyloid plaques and neurofibrillary
Direct Toxicity Hypothesis: β-Amyloid Directly Impairs Choli 0.769 - Do β-amyloid plaques and neurofibrillary
Exposed amyloidogenic segments (β-sheet propensity residues) 0.761 protein biochemistry Do chaperones selectively recognize path
Test: TREM2 enhances amyloid clearance 0.755 - Test Hypothesis Fixtures
Stage-Specific TREM2 Biomarker-Guided Switching — Agonist in 0.735 Alzheimer's disease TREM2 agonism vs antagonism in DAM micro
Bacterial Curli Amyloid → Nucleation of α-Synuclein Misfoldi 0.720 neurodegeneration What are the mechanisms by which gut mic
Test: TREM2 enhances amyloid clearance 0.712 - Test Hypothesis Fixtures
Excess orexin-A worsens AD cognition through wake-driven amy 0.711 neurodegeneration Orexin-A manipulation in AD cognition an
Test: TREM2 enhances amyloid clearance 0.705 - Test Hypothesis Fixtures
TREM2 Microglial Activation Rescues Amyloid Clearance in AD 0.680 neurodegeneration Test Hypothesis Fixtures
Test: TREM2 enhances amyloid clearance 0.655 - Test Hypothesis Fixtures
Amyloid-beta induces secondary pericyte senescence after con 0.640 neurodegeneration Does pericyte senescence drive BBB break
Stage-Selective TREM2 Agonism — Boosting DAM Phagocytosis in 0.637 Alzheimer's disease TREM2 agonism vs antagonism in DAM micro
Test: TREM2 enhances amyloid clearance 0.637 - Test Hypothesis Fixtures
Pericyte senescence is sufficient to weaken the BBB even wit 0.630 neurodegeneration Does pericyte senescence drive BBB break
APOE4-microglial complement signaling causes cholinergic-enr 0.630 neurodegeneration What determines the temporal sequence of
Microglial ACE Enhancement for Amyloid Clearance 0.622 neurodegeneration Gene expression changes in aging mouse b
Locus coeruleus degeneration gates whether cholinergic dysfu 0.620 neurodegeneration What determines the temporal sequence of
APOE4-driven loss of neuronal PI(4,5)P2 bridges ganglioside- 0.000 Alzheimer disease Lipid metabolism dysregulation and membr
Gut-derived butyrate reprograms microglia for amyloid cleara 0.000 Alzheimer's disease Gut-Brain Axis Therapeutics for AD
Gut butyrate deficiency impairs microglial amyloid clearance 0.000 Alzheimer's disease Gut-Brain Axis Therapeutics for Alzheime
Amyloidogenic segments undergo conformational templating by 0.000 protein biochemistry Do chaperones selectively recognize path
HSP70 recognition of exposed β-sheet segments triggers CHIP- 0.000 protein biochemistry Do chaperones selectively recognize path
HSP90-CDC37 complex recognizes exposed hydrophobic clusters 0.000 protein biochemistry Do chaperones selectively recognize path
Exposed amyloidogenic segments trigger CHIP-mediated oligome 0.000 protein biochemistry Do chaperones selectively recognize path

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (2)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
TREM2 KO amyloid pathology study validation Alzheimers Disease 0.800 0.00 Mouse (5xFAD/TREM2-/-) completed N/A
Closed-loop tFUS Enhances Glymphatic Clearance and Restores CA1 PV Int in_vivo Alzheimer's disease 0.765 0.55 APP/PS1 mice 8-11 months (n=10 proposed $125,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2- [PMID:31932797] Zhou Y, Song WM, Andhey PS, Swain A, Lev Nat Med 2020 1
Integrative Multiomics Insights into the Genetic and Epigenetic Architecture of [PMID:41422555] Mishra AK, Jain S ACS Chem Neurosci 2026 0
The association of Alzheimer's disease-related SNPs with mild cognitive impairme [PMID:41606232] Xie Z, Tu W, Ye XF, Hua L, Zhang X et al Sci Rep 2026 0
Genetic risk factors of late-onset Alzheimer's disease: Insights into pathophysi [PMID:41622452] Akkaoui J, Devadoss D, Rodriguez MD, Ari Neural Regen Res 2026 0
Genetic Burden and <i>APOE</i> Methylation in a Korean Multi-Generational Alzhei [PMID:41745359] Eom Je-Hyun; Cho Mu-Yeol; Kim Ji-Won; Ki Journal of personalized medici 2026 0
Genetic Architecture of Cognitive Resilience in Alzheimer's Disease: Mechanisms, [PMID:41893052] Burdman Gabriel; Akkaoui Juliet; Colon N Neurology international 2026 0
Posttraumatic stress disorder is associated with Alzheimer's disease-relevant mo [PMID:41960318] Seijo MA, Yohannes PA, Rogers AL, Gonzal Res Sq 2026 0
Genetic risk factors of late-onset Alzheimer's disease: Insights into pathophysi [PMID:41622452] Akkaoui J, Devadoss D, Rodriguez MD, Ari Neural regeneration research 2026 0
Genetic Architecture of Cognitive Resilience in Alzheimer's Disease: Mechanisms, [PMID:41893052] ["Burdman G", "Akkaoui J", "Colon N", "P Neurology international 2026 0
Retinal Müller glia alterations and their impact on ocular glymphatic clearance [PMID:41603340] Das G, Raghunathan R, Wang L J Alzheimers Dis 2026 0
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] ["Chen Kai", "Li Fuyao", "Zhang Shuwen", Journal of neuroinflammation 2025 0
The Glymphatic-Venous Axis in Brain Clearance Failure: Aquaporin-4 Dysfunction, [PMID:41226584] ["Costea D", "Dobrin N", "Tataru C", "To International journal of molec 2025 0
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] ["Chen Kai", "Li Fuyao", "Zhang Shuwen", Journal of neuroinflammation 2025 0
Longitudinal changes of blood-brain barrier and transcytolemmal water exchange p [PMID:40089221] Xiong C, Yu Z, Yin Y Neuroimage 2025 0
The future of biomarkers for vascular contributions to cognitive impairment and [PMID:40542975] Lennon MJ, Karvelas N, Ganesh A Geroscience 2025 0
P-tau217 correlates with neurodegeneration in Alzheimer's disease, and targeting [PMID:38513667] Zhang D, Zhang W, Ming C, Gao X, Yuan H, Neuron 2024 0
The necroptosis cell death pathway drives neurodegeneration in Alzheimer's disea [PMID:38852117] Balusu S, De Strooper B Acta neuropathologica 2024 0
α7nAChR activation in AT2 cells promotes alveolar regeneration through WNT7B sig [PMID:37410546] Unknown JCI Insight 2023 0
Oxidized phosphatidylcholines found in multiple sclerosis lesions mediate neurod [PMID:33603230] Dong Y, D'Mello C, Pinsky W, Lozinski BM Nature neuroscience 2021 0
Insulin Resistance and Diabetes Mellitus in Alzheimer's Disease. [PMID:34069890] Burillo J, Marqués P, Jiménez B, Gonzále Cells 2021 0

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning AMYLOID in their description or question text

Vicious Cycle Hypothesis: Cholinergic Dysfunction Exacerbates Amyloid Pathology

Score: 0.785 · unknown disease · 2026-04-12

## Mechanistic Overview Vicious Cycle Hypothesis: Cholinergic Dysfunction Exacerbates Amyloid Pathology starts from the

Direct Toxicity Hypothesis: β-Amyloid Directly Impairs Cholinergic Signaling

Score: 0.769 · unknown disease · 2026-04-12

## Mechanistic Overview Direct Toxicity Hypothesis: β-Amyloid Directly Impairs Cholinergic Signaling starts from the cla

Exposed amyloidogenic segments (β-sheet propensity residues) serve as HSP70 reco

Score: 0.761 · protein biochemistry · 2026-04-21

## **Molecular Mechanism and Rationale** The recognition of amyloidogenic protein species by the heat shock protein 70

Test: TREM2 enhances amyloid clearance

Score: 0.755 · unknown disease · 2026-04-17

## Mechanistic Overview Test: TREM2 enhances amyloid clearance starts from the claim that modulating not yet specified w

Stage-Specific TREM2 Biomarker-Guided Switching — Agonist in Amyloid Phase, Anta

Score: 0.735 · Alzheimer's disease · 2026-04-04

## Mechanistic Overview Stage-Specific TREM2 Biomarker-Guided Switching — Agonist in Amyloid Phase, Antagonist in Tau Ph

Bacterial Curli Amyloid → Nucleation of α-Synuclein Misfolding in Enteric Neuron

Score: 0.720 · neurodegeneration · 2026-04-22

**Molecular Mechanism and Rationale** The molecular basis of this hypothesis centers on the structural and biochemical

Test: TREM2 enhances amyloid clearance

Score: 0.712 · unknown disease · 2026-04-17

## Mechanistic Overview Test: TREM2 enhances amyloid clearance starts from the claim that modulating not yet specified w

Excess orexin-A worsens AD cognition through wake-driven amyloid production

Score: 0.711 · neurodegeneration · 2026-04-26

Chronic orexin-A elevation may aggravate AD by extending wakefulness, fragmenting circadian rhythms, and increasing acti

Test: TREM2 enhances amyloid clearance

Score: 0.705 · unknown disease · 2026-04-04

**Background and Rationale** Test: TREM2 enhances amyloid clearance is a mechanistic proposition centered on the idea t

TREM2 Microglial Activation Rescues Amyloid Clearance in AD

Score: 0.680 · neurodegeneration · 2026-04-26

TREM2 agonistic antibodies restore microglial phagocytosis and plaque compaction in Alzheimer's disease, particularly fo

Test: TREM2 enhances amyloid clearance

Score: 0.655 · unknown disease · 2026-04-17

**Molecular Mechanism and Rationale** TREM2 (Triggering Receptor Expressed on Myeloid cells 2) represents a critical mi

Amyloid-beta induces secondary pericyte senescence after contractile and oxidati

Score: 0.640 · neurodegeneration · 2026-04-25

Soluble Aβ oligomers trigger endothelin-1 and ROS-dependent pericyte contractile stress, and repeated exposure converts

Stage-Selective TREM2 Agonism — Boosting DAM Phagocytosis in Early Amyloid Phase

Score: 0.637 · Alzheimer's disease · 2026-04-04

## Mechanistic Overview Stage-Selective TREM2 Agonism — Boosting DAM Phagocytosis in Early Amyloid Phase starts from the

Test: TREM2 enhances amyloid clearance

Score: 0.637 · unknown disease · 2026-04-17

**Molecular Mechanism and Rationale** TREM2 (Triggering Receptor Expressed on Myeloid cells 2) functions as a critical

Pericyte senescence is sufficient to weaken the BBB even without classic amyloid

Score: 0.630 · neurodegeneration · 2026-04-25

Selective induction of a senescence program in adult pericytes is sufficient to impair barrier-supportive trophic signal